Superficial thrombophlebitis (Mondor's Disease) after breast augmentation surgery

Viana, Giovanni André Pires; Okano, Fabrício Macedo

doi:10.4103/0970-0358.44940

Cited by 14 publications

(9 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Fibrosis, and consequent hardening of the breast, was seen in a single case by Yoshimura et al. 2008 24 and an isolated case of Mondor's disease (a rare condition that leads to thrombophlebitis of the superficial veins of the breast and anterior chest wall 29 ) was reported by Dos Anjos et al. 2015 23 .…”

Section: Resultsmentioning

confidence: 99%

Cell assisted lipotransfer in breast augmentation and reconstruction: A systematic review of safety, efficacy, use of patient reported outcomes and study quality

et al. 2016

View full text Add to dashboard Cite

BackgroundCell assisted lipotransfer serves as a novel technique for both breast reconstruction and breast augmentation. This systematic review assesses the efficacy, safety and use of patient reported outcome measures in studies involving cell assisted lipotransfer. We also carry out an objective assessment of study quality focussing on recruitment, follow-up and provide an up-to-date clinical trial landscaping analysis.MethodsKey electronic databases were searched according to PRISMA guidelines and pre-defined inclusion and exclusion criteria. Two independent reviewers examined the retrieved publications and performed data extraction.Results3980 publications were identified. Following screening, 11 studies were included for full review, representing a total of 336 patients with a follow-up time ranging from six to 42 months. A degree of variation was noted in graft retention and reported satisfaction levels, although there were only three comparative studies with conflicting results. Complications occurred at a rate of 37%. Additionally, there was a paucity of objective outcomes assessments (e.g. 3D assessment modalities or validated patient reported outcome measures) in the selected studies.ConclusionsCell assisted lipotransfer is a surgical technique that is currently employed sparingly within the plastic & reconstructive surgery community. Presently, further technical and outcome standardization is required, in addition to rigorous randomized controlled trials and supporting long-term follow-up data to better determine procedural safety and efficacy. Routine use of more objective outcome measures, particularly 3D assessments and validated patient reported outcome measures, will also help facilitate wider clinical adoption and establish procedural utility.

show abstract

Section: Resultsmentioning

confidence: 99%

Cell assisted lipotransfer in breast augmentation and reconstruction: A systematic review of safety, efficacy, use of patient reported outcomes and study quality

et al. 2016

View full text Add to dashboard Cite

show abstract

“…They are most often treated with non-steroidal anti-inflammatory drugs and heparin ointment. Some doctors recommend low molecular weight heparin [ 6 – 8 ]. With general symptoms, fever and leukocytosis it is recommended to administer an antibiotic.…”

Section: Discussionmentioning

confidence: 99%

Mondor's disease in a patient after a mammotome biopsy.

Kibil

Hodorowicz-Zaniewska

Kulig

2015

Videosurgery and Other Miniinvasive Techniques

View full text Add to dashboard Cite

Mondor's disease is a rare, benign condition characterised by thrombophlebitis affecting subcutaneous veins of the chest and/or abdomen without an accompanying inflammatory response. The disease has a multifactorial etiology and its course is benign. It is usually self-limiting or it is eliminated by local treatment. Mondor's disease in the thoracoepigastric region may be a rare complication of mammotome biopsy. The case presentation describes a 32-year-old patient with Mondor's disease in the thoracoepigastric region after an ultrasound-guided mammotome biopsy of a breast. In the histopathological examination the lesion was diagnosed as fibroadenoma. Regardless of the disease's etiology, it is recommended to carry out diagnostic examinations to exclude co-occurring breast cancer.

show abstract

“…Although the diagnosis of Mondor's disease can be made accurately on the basis of clinical history and findings (Viana & Okano, 2008), patients should undergo a rigorous diagnostic evaluation to determine the cause. Hidden breast cancer or lymphatic spread from carcinoma, a state of hypercoagulability, or connective tissue diseases are some of the causes that have been associated with Mondor's disease (Kikano et al, 1991).…”

Section: Assessment and Diagnosismentioning

confidence: 99%